North America Dietary Supplements Market Size to register a growth of 9.7% CAGR during the forecast period

10-05-2018 | Report Format: Electronic (PDF)

Growth, Trends and Report Highlights

According to a new report North America Dietary Supplements Market, published by KBV research, the North America Dietary Supplements Market Size would witness market growth of 9.7% CAGR during the forecast period (2017-2023).

The Tablets & Capsules market holds the largest market share in North America Dietary Supplements Market by Product in 2016 and would continue to be a dominant market till 2023. The Liquids market is expected to witness a CAGR of 11% during (2017-2023). Additionally, The Soft Gels market is expected to witness a CAGR of 10.8% during (2017-2023).

The US market holds the largest market share in North America Vitamins & Minerals Dietary Supplements Market by Country in 2016 and would continue to be a dominant market till 2023; growing at a CAGR of 8.3 % during the forecast period. The Canada market is expected to witness a CAGR of 11.7% during (2017-2023) in North America Botanicals Dietary Supplements Market. Additionally, The Mexico market is expected to witness a CAGR of 12.6% during (2017-2023) in North America Amino Acids Dietary Supplements Market.

The Adults market holds the largest market share in Mexico Dietary Supplements Market by End User in 2016 and would continue to be a dominant market till 2023; growing at a CAGR of 10.5 % during the forecast period. The Children market would attain market value of $898.4 million by 2023. Additionally, The Pregnant Woman market is expected to witness highest CAGR of 13.5% during (2017-2023).

Full Report: https://www.kbvresearch.com/north-america-dietary-supplements-market/

The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the countries in the region. The key impacting factors of the North America Dietary Supplements Market have been discussed in the report with the elaborated company profiles of Abbott Laboratories, The Carlyle Group, GlaxoSmithKline plc, Alticor (Amway), Glanbia, Plc. (Glanbia Nutritionals), Bayer AG, Archer Daniels Midland Company, E. I. Du Pont De Nemours and Company, Nutraceutics Inc., and Pfizer, Inc.